Risk factors
Amneal Pharmaceuticals (AMRX) risk factors
Item 1A of every Amneal Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors57 risks6 new2 dropped20 reworded
New risks focus on supply continuity, including third-party APIs, a multi-year ERP rollout, and possible U.S. government shutdown delays.
Filed Feb 27, 2026 - FY2024 10-K risk factors53 risks
Amneal Pharmaceuticals relies heavily on four major customers representing seventy percent of net sales and carries two point six billion dollars in debt. The company faces intense generic and brand competition, concentration risks in product families and manufacturing sites, and rigorous regulatory oversight.
Filed Feb 28, 2025